In-vitro antimicrobial susceptibility of the 'Streptococcus milleri' group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 2, 1996, Pages 371-375

  Jacobs, Jan A ^a   Stobberingh, Ellen E ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; PENICILLIN G; ROXITHROMYCIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; HUMAN; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MILLERI;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; STREPTOCOCCUS;

EID: 0029994617     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.2.371     Document Type: Article

References (10)

1. Gómez-Garcés, J. L., Alós, J. I. & Cogollos, R. (1994). Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group. Diagnostic Microbiology and Infectious Diseases 19, 69-73.
2. Gossling, J. (1988). Occurrence and pathogenicity of the Streptococcus milleri group. Reviews of Infectious Diseases 10, 257-85.
3. Horaud, T., Le Bouguenec, C. & Pepper, K. (1985). Molecular genetics of resistance to macrolides, lincosamides and streptogamin B (MLS) in streptococci. Journal of Antimicrobial Chemotherapy 16, Suppl. A, 111-35.
4. Jacobs, J. A., Pietersen, H. G., Stobberingh, E. E. & Soeters, P. B. (1994). Bacteremia involving the "Streptococcus milleri" group: analysis of 19 cases. Clinical Infectious Diseases 19, 704-13.
5. LePennec, M. P. & Berardi-Grassias, L. (1989). In-vitro activity of 13 antibiotics against clinical isolates of Streptococcus milleri. Journal of Antimicrobial Chemotherapy 24, 618-9.
6. National Committee for Clinical Laboratory Standards. (1994). Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically, 3rd edition; Approved Standard M7-A3. NCCLS, Villanova, PA.
7. Potgieter, E., Carmichael, M., Koornhof, H. J. & Chalkley, L. J. (1992). In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. European Journal of Clinical Microbiology and Infectious Diseases 11, 543-6.
8. Quinn, J. P., DiVincenzo, C. A., Lucks, D. A., Luskin, R. L., Shatzer, K. L. & Lenner, S. A. (1988). Serious infections due to penicillin-resistant strains of viridans streptococci with altered penicillin-binding proteins. Journal of Infectious Diseases 157, 764-9.
9. Whiley, R. A. & Beighton, D. (1991). Emended descriptions and recognition of Streptococcus anginosus, Streptococcus intermedius and Streptococcus anginosus as distinct species. International Journal of Systematic Bacteriology 41, 1-5.
10. Whiley, R. A., Fraser, H., Hardie, J. M. & Beighton, D. (1990). Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus,and Streptococcus anginosus strains within the "Streptococcus milleri" group. Journal of Clinical Microbiology 28, 1497-501.